Clinical Trial Update: Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA [Phase 3]

View source ↗

Summary

A Phase 3 study comparing an intravenous regimen of secukinumab to placebo in adults with active axial spondyloarthritis (ankylosing spondylitis) has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Axial Spondyloarthritis

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED | Results posted: 2024-01-23